1202 SEQUENCE ANALYSIS OF HCV VARIANTS FROM A PHASE IIA TRIAL OF MIRAVIRSEN (MIR), AN OLIGONUCLEOTIDE TARGETING MIR-122, IN TREATMENT NAIVE PATIENTS WITH CHRONIC HCV INFECTION
2012
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
7
Citations
NaN
KQI